Page 6 - Micro Labs News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Get latest articles and stories on Business at LatestLY. New Delhi [India], August 16: Micro Labs Ltd, a renowned pharmaceutical company, proudly announced the launch of Trisopt, the world's first fixed-dose combination of Brimonidine, Timolol, and Brinzolamide ophthalmic suspension for glaucoma management. Trisopt is an indigenous development from Micro Labs, manufactured in their state-of-the-art facility located in Sikkim. Business News | Micro Labs Ltd Introduces Trisopt: World's First Triple Drug Fixed-dose Combination for Glaucoma Management.

The top 300 pharmaceutical brands in the country will now bear a quick response (QR) code on their packaging to rein in spurious drugs and ensure better traceability.

In a conflict-affected region, many people struggle with insomnia and seek solace in sleeping pills. The long-term dependence on these medications has serious consequences for mental and physical health. The pandemic-induced stress has also contributed to rising insomnia cases. Despite regulations, the easy availability of these pills without prescriptions adds to the problem. Experts emphasise the importance of alternative treatments like cognitive-behavioral therapy and lifestyle modifications. Increased investment in mental health resources and support structures is crucial to address the i...

Pharma companies in India are struggling to enforce compounds that are covered by both genus and subsequent species patents. While the latest case involved a series of injunctions being vacated, the patent community is still unsatisfied by the lack of concrete judgments on this issue.

Dilip Surana News, Chairman and MD of Micro Labs, Surana Family Net Worth, Businesses, residence and more, Business News, Times Now